MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/qims-24-553

Медицинская библиотека · Quantitative imaging in medicine and surgery · 2024

Mean liver density independently predicts therapeutic response and liver-related mortality in patients with primary biliary cholangitis.

Wang Zilong, Yang Shuo, Zhong Juan, Liu Xinyue, Feng Jiajun, Jin Qian, Ren Wenhui, Wang Jian, Ma Danli, Rao Huiying, Huang Rui

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Sarcopenia, myosteatosis, and sarcopenic obesity are known to adversely affect nutritional status and quality of life in cirrhotic patients. However, there is limited research on these conditions in individuals with primary biliary cholangitis (PBC). This study aims to identify risk factors for sarcopenia, myosteatosis, and sarcopenic obesity in PBC patients and to investigate their association with therapeutic outcomes and liver-related mortality. Furthermore, this research aims to uncover novel imaging-based risk factors that may influence biochemical response rates and mortality risk.

METHODS

In this retrospective study, patients with PBC were enrolled. Sarcopenia and myosteatosis were defined using the third lumbar vertebra (L3) skeletal muscle index (SMI) and skeletal muscle density (SMD) obtained from computed tomography (CT) imaging. The prognosis of PBC patients can be accurately evaluated using the PARIS I criteria.

RESULTS

The study included 117 PBC patients, of whom 73 (62.4%) exhibited sarcopenia and 51 (43.6%) presented with myosteatosis. Seventeen (14.5%) patients were with sarcopenic obesity. The rate of biochemical response was 38.5%. During a mean follow-up period of 68 months, seven patients died. Patients with sarcopenia were older, with a lower body mass index (BMI) and a higher prevalence of myosteatosis, as well as lower visceral adipose tissue index (VATI) and subcutaneous adipose tissue index (SATI) levels (P<0.05). Patients with myosteatosis were older and had higher levels of albumin, SATI, and VATI (P<0.05). They also had a higher prevalence of sarcopenia and sarcopenia obesity (P<0.05). Multivariate analysis revealed that neither sarcopenia nor myosteatosis impacted the biochemical response rates or liver-related mortality in PBC patients. Conversely, mean liver density was identified as a significant risk factor for biochemical response and liver-related mortality (P<0.05).

CONCLUSIONS

Mean liver density is an independent predictor for biochemical response and liver-related mortality in patients with PBC.

Для цитирования: Wang Zilong, Yang Shuo, Zhong Juan, Liu Xinyue, Feng Jiajun, Jin Qian, Ren Wenhui, Wang Jian, Ma Danli, Rao Huiying, Huang Rui. Mean liver density independently predicts therapeutic response and liver-related mortality in patients with primary biliary cholangitis.. Quantitative imaging in medicine and surgery. 2024. DOI: 10.21037/qims-24-553.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.